default image

Strahlentherapie

Information and services of the department

  • Number of inpatient cases: 92

Services search (in the department)


Illness Number of cases
Malignant neoplasm of bronchus and lung (C34.1) 18
Malignant neoplasm of bronchus and lung (C34.3) 10
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0) 8
Malignant neoplasm of anus and anal canal - Malignant neoplasm of anal canal (C21.1) 8
Malignant neoplasm of tonsil - Malignant neoplasm of overlapping sites of tonsil (C09.8) 5
Malignant neoplasm of base of tongue (C01) not specified
Malignant neoplasm of other and unspecified parts of tongue - Malignant neoplasm of border of tongue (C02.1) not specified
Malignant neoplasm of gum - Malignant neoplasm of lower gum (C03.1) not specified
Malignant neoplasm of floor of mouth - Malignant neoplasm of lateral floor of mouth (C04.1) not specified
Malignant neoplasm of palate - Malignant neoplasm of soft palate (C05.1) not specified
Treatment Number
Radiotherapy with high-energy beams for cancer - high voltage radiotherapy (8-522.91) 81
(8-831.00) 30
Cancer treatment for several days (e.g. 5-8 days) with two or more chemotherapy drugs administered into a vein (8-544) 17
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.11) 16
Computer-assisted analysis of the images with 3D-analysis (3-990) 13
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22) 11
Uniform basic assessment in terminal care (1-774) 10
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.32) 9
(9-984.7) 9
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.42) 8

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
  • External quality assurance according to state law
    No participation
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
  • Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
    No participation
Number Group
15 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
15 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
15 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Doctoral supervision
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at colleges and universities
Editors of scientific journals/textbooks
Participation in multi-centre Phase I/II studies
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)
No. Training in other healing professions Comment
HB20 Nursing professional B. Sc.
HB05 Medical technical radiology assistant (MTRA) (m/f)

Traute Groß

Patientenfürsprecherin

Phone: 04141 -604-912
Mail: ed.nekcnah@rehcerpsreufnetneitap

Dr. Alexander Scherpe

Stell. Patientenfürsprecher

Phone: 04141 -604-912
Mail: ed.nekcnah@rehcerpsreufnetneitap

Iris Runge

Leiterin Qualitätsmanagement

Phone: 04141 -604-393
Mail: ed.nekcnah@mq

Iris Runge

Leiterin Qualitätsmanagement

Phone: 04141 -604-393
Mail: ed.nekcnah@mq

Dr. Christoph Hancken

Geschäftsführender Gesellschafter

Phone: 04141 -604-160
Mail: ed.nekcnah@ofni

Prof. Dr. Stefan Frühauf

Leitender Arzt

Phone: 04141 -604-370
Mail: ed.nekcnah@noitats